Product

    • CLite-160i
      Fully automatic chemiluminescence immunoassay analyzer
      The CLite-160i fully automatic chemiluminescence immunoassay analyzer adopts the alkaline phosphatase magnetic particle chemiluminescence method and is used in conjunction with the chemiluminescence reagents produced by our company. It is clinically used for quantitative detection of relevant analytes in human blood samples.
      SMART 500H
      Fully automatic chemiluminescence immunoassay analyzer
      Proprietary liquid level detection and control technology, highly integrated modular design, the smallest instrument in the industry at the same speed, highly cost-effective, original structure, compact and flexible, can be used in medical institutions and places at all levels, easy to operate, and ideal for rapid inspection and luminescence projects The best choice, can be used in clinical examination, emergency department, POCT and other examination scenarios
      Evidence Investigator
      Evidence Investigator is a small, semi-automatic biochip analyzer that enables immunological and molecular diagnosis on this platform. The analyzer uses biochip array technology to simultaneously detect multiple analytes from a single sample to obtain comprehensive and accurate results. Cost-effective screening that is fast, accurate and easy.
      Microarray chip analyzer
      Vivalytic
      Fully automatic microfluidic biochip analyzer
      Vivalytic is a fully automated molecular diagnostic system that can complete target gene extraction, PCR setup, amplification and detection in one step in a short time, achieving a one-stop user experience from sample to result.It can be used both quantitatively and qualitatively, and is compatible with a variety of detection methods, including RT-PCR, melting curves, microarray chips, etc.
      • product name
        Specifications
        expected usage
        Detection platform
        NT-proBNP
        30 tests/box, 60 test/box
        Used for auxiliary diagnosis of heart failure and has high diagnostic value for heart failure
        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H
        hs-cTnI
        30 tests/box, 60 test/box
        It has high myocardial specificity and sensitivity and is currently the most ideal marker to assist in the diagnosis of acute myocardial infarction.
        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H
        CK-MB
        30 tests/box, 60 test/box

        Diagnose AMI, evaluate the effect of thrombolytic treatment, evaluate re-embolization, embolization scope and risk level
        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H
        Myo
        30 tests/box, 60 test/box
        Early diagnosis of acute myocardial infarction
        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H
        H-FABP
        30 tests/box, 60 test/box
        H-FABP can detect early myocardial damage caused by acute coronary syndrome, and can also detect myocardial damage in patients with heart failure, viral myocarditis, trauma, and sleep apnea syndrome. It is useful for judging acute pulmonary embolism, heart failure, It has good prognosis value for patients with chronic thromboembolic pulmonary hypertension and acute cerebral infarction.
        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H
        hs-CRP
        30 tests/box, 60 test/box
        For the assessment of cardiovascular disease, an indicator reflecting the risk of cardiovascular disease
        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H

        Lp-PLA2
        30 tests/box, 60 test/box
        Lp-PLA2 is an independent risk factor that reflects atherosclerotic plaque rupture and thrombotic events. It is highly consistent and accurate and is an accurate risk assessment marker for patients with high risk of recurrent acute atherosclerotic thrombotic events.

        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H

        MPO
        30 tests/box, 60 test/box

        Elevated MPO levels in the body indicate the risk of arteriosclerosis and coronary heart disease, and are an early warning of myocardial infarction. MPO levels can increase significantly within 2 hours of chest pain. Therefore, for patients with chest pain, MPO is important for diagnosing acute coronary artery disease. Syndrome (ACS) will have more clinical significance.

        CLite-160i
        50 tests/box, 100 test/box
        SMART 500H



      • product name
        		Specifications
        		expected usage
        		Detection platform
        hs-CRP
        		30 tests/box, 60 test/box
        		For the assessment of cardiovascular disease, an indicator reflecting the risk of cardiovascular disease
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H
        IL-6
        		30 tests/box, 60 test/box
        		IL-6 levels increase when cardiovascular and cerebrovascular diseases, kidney diseases, tumors, arthritis, trauma, infection and other diseases occur.The increased level of IL-6 is closely related to the active stage of the disease, the development and changes of the tumor, the degree of rejection and the effect of treatment.Therefore, the detection of IL-6 levels in patients' body fluids can reflect changes in the patient's condition.
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H
        PCT
        		30 tests/box, 60 test/box
        		Diagnose bacterial infections and viral infections, assist in the differential diagnosis of SIRS/sepsis, evaluate antibiotic treatment effects, accurately guide antibiotic use, and avoid antibiotic abuse
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H
        SAA
        		30 tests/box, 60 test/box
        		It is used in auxiliary diagnosis of infectious diseases, prediction of coronary heart disease risk, dynamic observation of efficacy and prognosis of tumor patients, observation of transplant rejection, and observation of improvement of rheumatoid arthritis.
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H
      • Product name
        		Specification
        		expected usage
        		Detection platform
        PGI30 tests/box, 60 test/box
        		Markers for judging new pathological changes in gastric mucosal atrophy, sensitive serological markers for early diagnosis of gastric cancer, evaluation indicators for the effectiveness of Helicobacter pylori eradication treatment, and indicators for determining recurrence of gastric cancer after resection 
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H
        PGII
        		30 tests/box, 60 test/box
        		Markers for judging new pathological changes in gastric mucosal atrophy, sensitive serological markers for early diagnosis of gastric cancer, evaluation indicators for the effectiveness of Helicobacter pylori eradication treatment, and indicators for determining recurrence of gastric cancer after resection 
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H
        G17
        		30 tests/box, 60 test/box
        		Serum G-17g indicates the functional status of the patient's gastric mucosa and is used for screening of gastric cancer and precancerous diseases. 
        		CLite-160i
        50 tests/box, 100 test/box
        		SMART 500H